Clinical Trial Update: Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump [Phase 4]

View source ↗

Summary

Phase 4 trial comparing basal insulin glycemic control with Degludec versus Aspart delivered via pump in Type 1 diabetes; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Aspart (insulin aspart)
• Degludec (degludec)

Snippet

Sponsor: Mountain Diabetes and Endocrine Center | Conditions: Type1 Diabetes Mellitus | Phase 4 | Status: COMPLETED